r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with Amyloidosis in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Al Azzam, W; Antoni, G; Bergström, M; Biswas, S; Chen, C; Cheriyan, J; Cleveland, M; Cookson, L; Falk, RH; Galette, P; Janiczek, RL; Kwong, RY; Lukas, MA; Millns, H; Richards, D; Schneider, I; Solomon, SD; Sörensen, J; Storey, J; Thompson, D; van Dongen, G; Vugts, DJ; Wall, A; Wechalekar, A; Wikström, G | 1 |
Cookson, L; Lukas, MA; Millns, H; Richards, D | 1 |
Pepys, MB; Pepys-Vered, ME | 1 |
Barton, SV; Berges, AC; Cookson, LM; Fontana, M; Gillmore, JD; Hawkins, PN; Lane, T; Moon, JC; Pepys, MB; Pinzani, M; Richards, DB; Ritter, JM | 1 |
Kolstoe, SE; Wood, SP | 1 |
Hutchinson, WL; Millar, DJ; Pepys, MB | 1 |
Gironella-Mesa, M; Martínez-Valle, F; Solans-Laqué, R | 1 |
Eikelenboom, P; Lemstra, AW; Meijer, EW; van Gool, WA | 1 |
Hirschfield, GM | 1 |
Gillmore, JD; Hawkins, PN | 1 |
Alanine, A; Bartfai, T; Gallimore, JR; Hawkins, PN; Herbert, J; Hertel, C; Hoffmann, T; Hutchinson, WL; Jakob-Roetne, R; Kemp, JA; Kolstoe, S; Lachmann, HJ; Lovat, LB; Murray, S; Norcross, RD; Pepys, MB; Purvis, A; Suzuki, M; Taylor, GW; Tennent, GA; Thompson, D; Wood, SP; Yamamura, K | 1 |
4 review(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Amyloidosis
Article | Year |
---|---|
Drug targets for amyloidosis.
Topics: Amyloidosis; Animals; Carboxylic Acids; Cross-Linking Reagents; Drug Delivery Systems; Humans; Models, Biological; Models, Molecular; Neurodegenerative Diseases; Prealbumin; Protein Binding; Protein Multimerization; Pyrrolidines; Serum Amyloid P-Component | 2010 |
[New trends in the treatment of amyloidosis].
Topics: Amyloid; Amyloidosis; Carboxylic Acids; Humans; Immunotherapy; Propane; Protein Conformation; Pyrrolidines; Sulfonic Acids | 2012 |
Amyloidosis: a clinico-pathophysiological synopsis.
Topics: Acetylglucosamine; Amyloid; Amyloid beta-Protein Precursor; Amyloidosis; Amyloidosis, Familial; Carboxylic Acids; Flufenamic Acid; Humans; Immunotherapy; Peptides; Prealbumin; Protein Binding; Protein Folding; Protein Precursors; Proteoglycans; Pyrrolidines; Serum Amyloid P-Component | 2004 |
Drug Insight: emerging therapies for amyloidosis.
Topics: Alzheimer Disease; Amyloidosis; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carboxylic Acids; Diflunisal; Humans; Immunotherapy; Protein Folding; Pyrrolidines | 2006 |
3 trial(s) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Amyloidosis
Article | Year |
---|---|
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study.
Topics: Aged; Aged, 80 and over; Amyloidosis; Antibodies, Monoclonal; Carboxylic Acids; Cardiomyopathies; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; Male; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Pyrrolidines; Serum Amyloid P-Component; Time Factors; Treatment Outcome; United Kingdom; United States; Ventricular Function, Left; Ventricular Remodeling | 2022 |
An observational, non-interventional study for the follow-up of patients with amyloidosis who received miridesap followed by dezamizumab in a phase 1 study.
Topics: Amyloidosis; Carboxylic Acids; Follow-Up Studies; Humans; Plaque, Amyloid; Pyrrolidines; Serum Amyloid P-Component | 2022 |
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.
Topics: Adult; Aged; Amyloidosis; Antibodies, Monoclonal; Carboxylic Acids; Dose-Response Relationship, Drug; Humans; Immunoglobulin G; Immunoglobulin Light-chain Amyloidosis; Infusions, Intravenous; Liver; Middle Aged; Pyrrolidines; Radionuclide Imaging; Serum Amyloid P-Component | 2015 |
4 other study(ies) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Amyloidosis
Article | Year |
---|---|
Targeted treatment for amyloidosis.
Topics: Amyloid; Amyloidosis; Carboxylic Acids; Disease Management; Genetic Therapy; Humans; Molecular Targeted Therapy; Plaque, Amyloid; Prealbumin; Protein Stability; Pyrrolidines; Sequestering Agents; Serum Amyloid A Protein; Serum Amyloid P-Component | 2014 |
Immunoradiometric assay for human serum amyloid P component.
Topics: Alzheimer Disease; Amyloidosis; Blood Chemical Analysis; Carboxylic Acids; Enzyme-Linked Immunosorbent Assay; Humans; Immunoassay; Immunoradiometric Assay; Protein Stability; Pyrrolidines; Serum Amyloid P-Component | 2011 |
[Novel therapeutic approach to amyloidosis: no implications as yet for patients with Alzheimer's disease].
Topics: Alzheimer Disease; Amyloidosis; Carboxylic Acids; Humans; Protein Folding; Pyrrolidines; Serum Amyloid P-Component | 2002 |
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis.
Topics: Amyloidosis; Animals; Calcium; Carboxylic Acids; Cross-Linking Reagents; Crystallography, X-Ray; Dimerization; Humans; Inhibitory Concentration 50; Liver; Mice; Models, Molecular; Protein Binding; Protein Structure, Quaternary; Pyrrolidines; Serum Amyloid P-Component | 2002 |